CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 26 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $524,000 | -18.3% | 354,000 | +8.3% | 0.06% | +10.7% |
| Q4 2019 | $641,000 | -58.3% | 327,000 | +9.0% | 0.06% | -78.6% |
| Q3 2019 | $1,536,000 | +1921.1% | 300,000 | +435.7% | 0.26% | +648.6% |
| Q1 2016 | $76,000 | -77.5% | 56,000 | -72.0% | 0.04% | -75.5% |
| Q4 2015 | $338,000 | -12.9% | 200,000 | 0.0% | 0.14% | -35.3% |
| Q3 2015 | $388,000 | -35.5% | 200,000 | 0.0% | 0.22% | -28.2% |
| Q2 2015 | $602,000 | – | 200,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |